UROGENITAL NEOPLASMS
Clinical trials for UROGENITAL NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new UROGENITAL NEOPLASMS trials appear
Sign up with your email to follow new studies for UROGENITAL NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill targets Hard-to-Treat cancers with AKT1 mutation
Disease control OngoingThis early-stage study tests an experimental pill, ATV-1601, in people with advanced solid tumors (including certain breast, ovarian, and prostate cancers) that have a specific AKT1 gene mutation. The main goals are to check the drug's safety, find the best dose, and see how the …
Matched conditions: UROGENITAL NEOPLASMS
Phase: PHASE1 • Sponsor: Atavistik Bio, Inc • Aim: Disease control
Last updated May 26, 2026 04:06 UTC
-
NanoDoce expanded access program now closed
Disease control NO_LONGER_AVAILABLEThis program offered expanded access to NanoDoce for people with urogenital cancers who could not join other clinical trials. It was designed to provide treatment outside of a formal study. The program is no longer available.
Matched conditions: UROGENITAL NEOPLASMS
Sponsor: NanOlogy, LLC • Aim: Disease control
Last updated May 22, 2026 13:54 UTC